Interestingly, the CXCL13 antibody significantly antagonized RA synovial fluid-induced increases in EPC homing and angiogenesis, suggesting that CXCL13 is a vital attractant in EPC-mediated homing and angiogenesis during RA development. The gene discussed is CXCL13; the disease is rheumatoid arthritis.